YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer drops development of twice-daily weight loss pill

Posted online

Pfizer has ended development of a twice-daily weight loss pill.

Company officials said the pill, called danuglipron, caused significant weight loss in trial patients. However, they experienced high rates of adverse side effects.

Pfizer plans to develop a once-daily version of the pill starting next year.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences